The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: Can tyrosine kinase inhibitors replace donor lymphocyte infusions?

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: Can tyrosine kinase inhibitors replace donor lymphocyte infusions?'. Together they form a unique fingerprint.

Medicine & Life Sciences